Introduction: Chronic or uncontrolled activation of myeloid cells which includes monocytes, macrophages and dendritic cells (DCs) is a hallmark of immune-mediated inflammatory Diseases. There's an urgent need for the development of novel prescription drugs With all the capacity to impair innate immune cell overactivation less than inflammatory problems. Compelling proof https://win55.clinic/ban-ca